Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page
- CheckyesterdayChange DetectedRemoved related topics entries 'Ovarian cancer' and 'MedlinePlus Genetics' from the Related Topics section.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.4.2 is now shown on the page in place of Revision: v3.4.1.SummaryDifference0.0%

- Check37 days agoChange DetectedMinor release: site revision updated from v3.4.0 to v3.4.1; no visible changes to the study details page.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded 'Ovarian cancer' as a study condition/topic and included related topics such as MedlinePlus Genetics.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded a Show glossary option and updated metadata fields (Last Update Submitted that Met QC Criteria; Revision: v3.4.0; No FEAR Act Data). Removed the 'Ovarian cancer' term and several related topics (MedlinePlus Genetics), and older QC notes including 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' with Revision: v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.